Jane E. Huang

679 total citations
9 papers, 546 citations indexed

About

Jane E. Huang is a scholar working on Oncology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Jane E. Huang has authored 9 papers receiving a total of 546 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Genetics and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Jane E. Huang's work include Chronic Lymphocytic Leukemia Research (3 papers), Lymphoma Diagnosis and Treatment (3 papers) and Lung Cancer Research Studies (3 papers). Jane E. Huang is often cited by papers focused on Chronic Lymphocytic Leukemia Research (3 papers), Lymphoma Diagnosis and Treatment (3 papers) and Lung Cancer Research Studies (3 papers). Jane E. Huang collaborates with scholars based in United States, Switzerland and China. Jane E. Huang's co-authors include Mark A. Socinski, Peter G. Compton, Lisa Wang, David A. Karlin, Fang Ting Liang, Margaret Kolb, Wallace Akerley, Corey J. Langer, Leonardo Faoro and David C. Dale and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Infectious Diseases.

In The Last Decade

Jane E. Huang

9 papers receiving 536 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jane E. Huang United States 5 394 246 196 142 73 9 546
Yoshimasa Shiraishi Japan 17 435 1.1× 495 2.0× 108 0.6× 156 1.1× 55 0.8× 79 811
Christopher Di Simone United States 7 274 0.7× 107 0.4× 66 0.3× 114 0.8× 135 1.8× 10 591
Eugenia Giraldi Italy 11 247 0.6× 74 0.3× 107 0.5× 288 2.0× 72 1.0× 22 885
Umberto Conte United States 11 150 0.4× 154 0.6× 58 0.3× 106 0.7× 75 1.0× 27 360
Akiyuki Kanzaki Japan 14 718 1.8× 310 1.3× 217 1.1× 83 0.6× 22 0.3× 23 878
Hae‐Seong Nam South Korea 11 95 0.2× 265 1.1× 148 0.8× 53 0.4× 151 2.1× 32 498
Yizhuo Wang China 12 172 0.4× 66 0.3× 63 0.3× 124 0.9× 62 0.8× 46 470
Ola El‐Zammar United States 9 114 0.3× 146 0.6× 146 0.7× 53 0.4× 32 0.4× 22 386
Takuma Miura Japan 12 111 0.3× 58 0.2× 51 0.3× 57 0.4× 71 1.0× 42 441
T. Suedhoff Germany 8 229 0.6× 97 0.4× 195 1.0× 38 0.3× 187 2.6× 14 464

Countries citing papers authored by Jane E. Huang

Since Specialization
Citations

This map shows the geographic impact of Jane E. Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane E. Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane E. Huang more than expected).

Fields of papers citing papers by Jane E. Huang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jane E. Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane E. Huang. The network helps show where Jane E. Huang may publish in the future.

Co-authorship network of co-authors of Jane E. Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Jane E. Huang. A scholar is included among the top collaborators of Jane E. Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jane E. Huang. Jane E. Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Teuteberg, Winifred, Joel W. Neal, Alice C. Fan, et al.. (2021). Use of a computer model and care coaches to increase advance care planning conversations for patients with metastatic cancer.. Journal of Clinical Oncology. 39(28_suppl). 8–8. 1 indexed citations
2.
Yang, Haiyan, Bing Xiang, Yuqin Song, et al.. (2020). Zanubrutinib monotherapy for patients with relapsed or refractory non-germinal center diffuse large B-cell lymphoma: Results from a phase II, single-arm, multicenter, study.. Journal of Clinical Oncology. 38(15_suppl). e20051–e20051. 3 indexed citations
3.
Spigel, David R., P. Townley, David Waterhouse, et al.. (2011). Randomized Phase II Study of Bevacizumab in Combination With Chemotherapy in Previously Untreated Extensive-Stage Small-Cell Lung Cancer: Results From the SALUTE Trial. Journal of Clinical Oncology. 29(16). 2215–2222. 187 indexed citations
4.
Hainsworth, John D., Fang Ting Liang, Jane E. Huang, et al.. (2010). BRIDGE: An Open-Label Phase II Trial Evaluating the Safety of Bevacizumab + Carboplatin/Paclitaxel as First-Line Treatment for Patients with Advanced, Previously Untreated, Squamous Non-small Cell Lung Cancer. Journal of Thoracic Oncology. 6(1). 109–114. 48 indexed citations
5.
6.
Socinski, Mark A., Corey J. Langer, Jane E. Huang, et al.. (2009). Safety of Bevacizumab in Patients With Non–Small-Cell Lung Cancer and Brain Metastases. Journal of Clinical Oncology. 27(31). 5255–5261. 191 indexed citations
7.
8.
9.
Liles, W. Conrad, Jane E. Huang, Jo‐Anne H. van Burik, Raleigh A. Bowden, & David C. Dale. (1997). Granulocyte Colony‐Stimulating Factor Administered In Vivo Augments Neutrophil‐Mediated Activity against Opportunistic Fungal Pathogens. The Journal of Infectious Diseases. 175(4). 1012–1015. 106 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoshimasa Shiraishi Breakdown of academic impact, for papers by Christopher Di Simone Breakdown of academic impact, for papers by Eugenia Giraldi Breakdown of academic impact, for papers by Umberto Conte Breakdown of academic impact, for papers by Akiyuki Kanzaki Breakdown of academic impact, for papers by Hae‐Seong Nam Breakdown of academic impact, for papers by Yizhuo Wang Breakdown of academic impact, for papers by Ola El‐Zammar Breakdown of academic impact, for papers by Takuma Miura Breakdown of academic impact, for papers by T. Suedhoff
Rankless by CCL
2026